| 15.4 -2.61 (-14.49%) | 05-07 14:20 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 22.62 | 1-year : | 26.42 |
| Resists | First : | 19.37 | Second : | 22.62 |
| Pivot price | 16.78  |
|||
| Supports | First : | 14.09 | Second : | 10.84 |
| MAs | MA(5) : | 17.55 |
MA(20) : | 16.02 |
| MA(100) : | 20.05 |
MA(250) : | 23.8 |
|
| MACD | MACD : | 0.6 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 58.3 |
D(3) : | 71 |
| RSI | RSI(14): 48 |
|||
| 52-week | High : | 61.84 | Low : | 2.21 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ZEPP ] has closed above bottom band by 24.5%. Bollinger Bands are 48.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 18.16 - 18.25 | 18.25 - 18.34 |
| Low: | 17.71 - 17.8 | 17.8 - 17.9 |
| Close: | 17.86 - 18.01 | 18.01 - 18.16 |
Zepp Health Corporation, together with its subsidiaries, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and smart hearable products, home treadmill, sportswear, home appliances, and smart watch accessories under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.
Wed, 06 May 2026
FIL Limited reports 11.48M shares in Zepp Health (NASDAQ: ZEPP) amendment - Stock Titan
Fri, 24 Apr 2026
Zepp Health posts 2025 Form 20-F, offers free print copies - Stock Titan
Fri, 24 Apr 2026
Zepp Health Corporation Files 2025 Annual Report on Form 20-F - The Manila Times
Sun, 19 Apr 2026
Zepp Health: A Riskier Bet As Gross Margins Compress (Rating Downgrade) (NYSE:ZEPP) - Seeking Alpha
Sun, 19 Apr 2026
Loss-Making Zepp Health Corporation (NYSE:ZEPP) Set To Breakeven - Yahoo Finance
Sun, 15 Mar 2026
Earnings call transcript: Zepp Health’s Q4 2025 revenue surges 43% - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Technology
|
|
|
Industry:
Consumer Electronics
|
|
| Shares Out | 8 (M) |
| Shares Float | 89 (M) |
| Held by Insiders | 6.3 (%) |
| Held by Institutions | 52.4 (%) |
| Shares Short | 463 (K) |
| Shares Short P.Month | 362 (K) |
| EPS | -2.56 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.51 |
| Profit Margin | -15.5 % |
| Operating Margin | -4.6 % |
| Return on Assets (ttm) | -3.4 % |
| Return on Equity (ttm) | -17.2 % |
| Qtrly Rev. Growth | 43 % |
| Gross Profit (p.s.) | 11.72 |
| Sales Per Share | 30.6 |
| EBITDA (p.s.) | -2.92 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -26 (M) |
| Levered Free Cash Flow | -15 (M) |
| PE Ratio | -6.17 |
| PEG Ratio | 0 |
| Price to Book value | 1.16 |
| Price to Sales | 0.51 |
| Price to Cash Flow | -5.2 |
| Dividend | 0.4 |
| Forward Dividend | 0 |
| Dividend Yield | 2.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|